LACTB and infection: New Beta-Lactamase Inhibitor Combinations (BLICs), such as ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam, were used in 72 cases (18.3%), mainly in the management of infections due to carbapenem-resistant Enterobacterales (CRE).